Rx Medicare

Warnex Inc. (TSX:WNX) announced today that its Medical Laboratories division has launched a test for the detection of a mutation of the pandemic influenza A H1N1 virus, which is associated with resistance to Tamiflu?, a drug used for the treatment and prevention of the flu. The test specifically detects the H275Y mutation of the neuraminidase gene, which has been shown to cause resistance to Tamiflu.

Read More…

Related Posts

• Meridian Granted Special 510(k) Clearance To Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim To The TRU FLU(R) Test Package Insert
• Diagnostic Hybrids Receives FDA Emergency Use Authorization For D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
• FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus
• Swine Flu: NIAID Set To Launch Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates
• Cases Of The 2009 H1N1 Influenza A Virus Confirmed In Crawford And Miami Counties
• Development Of Rapid Approach To Identify Influenza A Virus Mutations And Drug Resistance
• EFPIA Response To The A (H1N1) Novel Influenza Virus
• WHO Recommends H1N1 Be Added To Next Year’s Seasonal Flu Virus
• UGL Unicco First To Embrace Ionator EXP Ionized Water Cleaner That Kills H1N1 Virus
• Poll: Forty Percent Of Americans Will Change Holiday Plans Due To H1N1 Virus
• U.S. Department Of Health And Human Services And The Ad Council Launch New Nationwide PSA Campaign Urging Vaccination Against The H1N1 Flu Virus
• Vaccination, Antivirals And Social Distancing May Blunt Impact Of H1N1 Influenza, Finds Epidemiological Modelling Study
• Statement By The Welsh Assembly Government On Latest Developments In Respect Of The Influenza A (H1N1) Swine Flu Pandemic
• H1N1 Health Alert: Children With Asthma At Greater Risk From H1N1 Influenza
• JohnsonDiversey Launches Comprehensive Web Site Dedicated To H1N1 And Other Infectious Disease Prevention Information

Tags: efficacy, h1n1, influenza, launches, mutation, resistance, tamiflur, test, virus, warnex

This entry was posted on Monday, August 31st, 2009 at 10:08 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.